chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccinated arm is cold; all day now getting hot; Still very sore arm; Burning and itching on the forearm and wrist of arm that got the injection.; Rash on forearm of opposite arm; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 29Apr2021 at 15:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as very healthy. The patient had unspecified outdoor allergies. Concomitant medications included norethisterone (NORA-BE), taken for birth control from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 15:05, within about 5 minutes of getting vaccinated, the patient experienced burning and itching on the forearm and wrist of arm that got the injection, rash on forearm of opposite arm. On 30Apr2021, 24 hours later, the vaccinated arm was cold all day and later it was getting hot and a little itchy at night and the patient had very sore arm in general. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included an unspecified treatment and the patient was referred to an allergist whom the patient was yet to consult. The clinical outcome of the events burning and itching on the forearm and wrist of arm, rash, cold vaccinated arm and later got hot, itchy at night and sore arm were resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Initial report received from a consumer (patient's parent) who is also a healthcare professional on 09 August 2012. A 17-year-old male patient, who had no known allergies and whose concomitant medications were not reported, received a dose of MENACTRA (lot number U4052AD, route and site of vaccination not reported) on 06 August 2012. 36 hours after vaccination, the patient developed nausea, flushing, burning of skin, myalgia, diarrhea and warm body core with cold extremities. Corrective medications and laboratory investigations were not reported. The patient's outcome was not recovered. List of documents held by sender: None.
Case number PHEH2015US022723, is an initial spontaneous report received from a pharmacist on 04 Nov 2015. This report refers to a 58-year-old male patient. Medical history was not reported. Concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: 157404) prefilled syringe (PFS) intramuscularly on an unknown date. On 22 Oct 2015, the patient developed infection at the injection site. It was reported that the vaccine was administered while the patient was an in-patient at the hospital and the patient was discharged from the hospital on 22 Oct 2015. Final outcome of the event was unknown. Causality was not reported.
slight headache, eyesight adversely affected: bright white objects extremely bright, as if my eyes were dilated. Lasted from time reported until 6PM.
Doses administered after more than 1 temperature excursion; It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021 at 4:12 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Apr-2021 at 4:12 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 59.26  No concomitant medication was reported.  On 6-Apr-2021,vaccine moved to fridge and vaccine BUD date was reported as 9-May-2021.  Condition of vaccine prior to administration was reported Not frozen.   On 15-Apr-2021,vaccine excursion time was 9am at 34 degree F temperature. On 16-Apr-2021,vaccine excursion time was 9am at 50 degree F temperature.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Patient said about 20 hours after first dose she felt lightheaded and dizzy (in addition to being nauseous). This subsided after ~24 hr.
I got a cold from my granddaughter. Along with the cold I got a very ticklish cough. Normal to me, my lungs got inflammation and congestion. What was abnormal to me was the ticklish response. The cough was also not productive. It was an annoying cough that wasn?t getting rid of anything. This lasted weeks. I was taking my albuterol inhaler more frequently which was sort of helpful. I went to a respiratory clinic where I was also put on prednisone. I had also had a very sore throat.
vaccinated with Covid-19 vaccine but still got diagnosed with Covid-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (non-serious), outcome "unknown", described as "vaccinated with Covid-19 vaccine but still got diagnosed with Covid-19".  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Fatigue; Chills; Excessive Vomitting; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), CHILLS (Chills) and VOMITING (Excessive Vomitting) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. unknown and unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included PREDNISONE, METHOTREXATE, TAMSULOSIN, LISINOPRIL, FAMOTIDINE (PEPCID AC) and LEVOTHYROXINE.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue) (seriousness criterion hospitalization), CHILLS (Chills) (seriousness criterion hospitalization) and VOMITING (Excessive Vomitting) (seriousness criterion hospitalization). At the time of the report, FATIGUE (Fatigue), CHILLS (Chills) and VOMITING (Excessive Vomitting) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
1-2 days post vaccine developed mild local redness, swelling. Suspect secondary  cellulitis to needle punch, vaccine itself.
Patient had first vaccine 4 weeks ago with no side effects. But after her second vaccine, patient said she immediately felt something was wrong with her vision, but did not tell vaccine provider. She waited 15 minutes as told to be monitored, then left. But after she got outside she realized her vision was really distorted. Unfortunately, she did not return to the pharmacy for help. She went to consult with her doctor today, (3 days after second vaccine) and was told she has fluid behind her retina of her right eye and was referred to eye specialist.
Arm swelling, pain in the arm and elbow, hot to the touch, muscle spasms in back, hand changed color( looked black/bluish) and hands felt numb.  Patient went to health care provider and they gave  you steroid and muscle relaxer.  Patient reported they are still experiencing pain.
Within 18 hours of administration, developed headache, myalgia, fatigue, GI distress (abdominal cramping, loss of appetite, and nausea) and low grade fever with chills. Symptoms continued for 24 hours. Fatigue and mild GI distress (loss of appetite) continued for another 48 hours. Treated with TYLENOL and fluids. Site pain developed with 24 hours after administration, with decreasing intensity over the next 72 hours.
Patient was vaccinated at 1:02 and within 5 minutes of been vaccinated, patient started complaining of headache and thirst but denies palpitation or difficulty breathing. O2 sat 98% on room air, HR 128. Although patient was alert and oriented to person, place and event, his speech was slightly slurred and he was pale, Vital signs O2 sat 98% on room air, HR 76, BP 132/70. Patient was injected with 0.15 mg of Epi at 1:10 Pm on the right thigh and again at 1:15 pm on the left thigh. At 1:20 pm patient was still oriented to person, place and event and was able to do serial math. Patient was still pale when the ambulance arrived, O2 sat remained at 98% on room air and patient was taken to the ER for observation.
The pt was vaccinated in 1981. In September 1982, the child developed left knee pain and swellling. In a physical exam on 9/28/82, the child was noted to walk with a slightly antalgic gait on the right side. Her right hip was not irritable. On 10/12/82, the pt presented with increased temperature and some synovial thickening in her knee, although she did have a full range of motion. On 12/28/82, the child was noted to be very difficult and uncooperative. She lacked approximately 20 to 25 degree extension in her right knee and approximately 10 degrees of extension in her left knee. The knees were somewhat swollen. At this time the pt was dx with juvenile rheumatoid arthritis. On 1/26/83, the child complained of 2 to 3 hours of morning stiffness with involvement of the left and right knee, left ankle, left elbow, and right wrist. It was noted at this time that the child had a mild pallor and some alopecia. Both knee were remarkable for obvious synovitis with effusions. Periodically from 1983-1985, the pt had flare-ups of uveitis secondary to juvenile rheumatoid arthritis.
None- vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   This case was linked to (Patient Link).
318 patients received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date). On 14-Sep-2021, EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant Medications details were provided. No Treatment Medications details were provided.   This case was linked to MOD-2021-364598 (Patient Link).
K62.89 - Rectal pain R42 - Dizziness R41.0 - Delirium R55 - Syncope R77.8 - Elevated troponin M25.552 - Left hip pain Z86.2 - Hx of thrombocytopenia M79.662 - Pain in left lower leg
Severe skull pain Headache  Vomiting  Diarrhea  Severe stomach pain  Chills  Fever  Body ache  Cough
Aug 23- received Flu and Shingles vaccines from Pharmacy, 2PM Aug 24- Symptoms experienced: Body aches, Feverish but not over 100.4 degrees, general malaise, flu symptoms but NO respiratory issues. Aug 25- Symptoms: Continued body ache and general flu symptoms that resolved in the afternoon. Aug 26- Symptoms: I woke up with severe vertigo (room was spinning while in bed), nausea, vomiting and unable to walk straight. Hearing loss and loud ringing in left ear. Went to Urgent Care. Given and prescribed anti nausea medication. Ears were clear. Symptoms resolved within 2-3 hours of symptoms onset. Final diagnosis: tinnitus. Aug 30- Went to ENT doctor. Ears were also clear. Diagnosis: Miniere's. Prescribed Prednisone, 17 day course to resolve hearing loss. Aug 31- Symptoms: 6AM in shower stall. Generalized weakness on the right side. Body was leaning towards the right side with my right leg unable to hold my weight.  Had to finally sit on shower floor. Unable to clench my right hand, left hand was OK. Unable to call out loudly for help, felt my mouth wasnt functioning. Visions blurred, foggy. Unable to stand up. Symptoms resolved within 10 minutes.  Went to Urgent Care again but staff suggested I contact ENT doctor as Urgent Care was limited in what they can do for me. ENT doctor strongly suggested I go to ER. I was admitted to Hospital for observations. Tests taken included MRI with or without contrast, MRI, Echocardiogram, Ultrasound to examine carotid arteries, blood tests including tests to rule out genetic blood clotting issues, neurology consult. Discharged from hospital on Sept 1. Final diagnosis: TIA. Prescribed aspirin and statins.
Covid test result: Positive; I was in Menopause and had not had a period or any bleeding for 15 months.  Exactly 3 weeks after my first dose, I got a period.; This is a spontaneous report from a contactable consumer (patient herself).   A 44-years-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number, Expiry date was not reported), via an unspecified route of administration, administered in Arm Left on 10Aug2021 at 14:45 (Age at vaccination 44-years-old) as single dose for COVID-19 immunisation (Pharmacy or Drug Store). The patient's medical history included multiple sclerosis, previous endometriosis from an unknown date and unknown if ongoing. The patient's concomitant medications included teriflunomide (AUBAGIO) taken for an unspecified indication, start and stop date were not reported. The patient was not pregnant at time of vaccination. The patient was in menopause and had not had a period or any bleeding for 15 months. Exactly 3 weeks after my first dose, the patient got a period. The patient was not on any birth control on an unspecified date Aug2021. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 21Aug2021 Nasal Swab. The patient did not receive treatment for the adverse event. Prior Vaccinations, the patient had not received any other vaccine within 4 weeks. Patient had not been diagnosed with COVID-19 prior to vaccination. The patient had been COVID tested positive post vaccination. The outcome of event i was in menopause and had not had a period or any bleeding for 15 months was recovered on an unspecified date and rest other events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient is a 83 y.o. male who presents today with cough, fatigue and shortness of breath.  Patient was ill with upper respiratory infection type symptoms on March 11, 2022.  Patient tested positive for COVID-19.  Patient was being treated with vitamin-C, aspirin and doxycycline.  Patient states that he continues to worsen.  Patient presented to the emergency department tachypneic with room air saturation of 84%.  He appeared to be in acute, moderate respiratory distress on arrival.  No objective fever or chills.  No nausea, vomiting or diarrhea reported.  No abdominal pain, rash or lower extremity swelling.  No focal neuro deficit.  GCS 15.  Patient has frequent nonproductive cough.  Patient is vaccinated against COVID-19 and also had a booster.  It appears to be a breakthrough case.  Patient vital signs are otherwise stable.  No evidence of acute sepsis.
Noticed "Red dots" on wrists, thigh, calves, a few on chest and face  within 24 hours after vaccine administration, Pt was not irritable. Rash not raised, Temperature = 99.7. Mom will see pediatrician on 10/01/02. Diagnosed with "broken blood vessels" without illness. Duration 1 week, May consult another doctor
Pt exp an allergic rxn p/recvd flu vax; addtl info has been requested;
Local muscle soreness - 12 hours. At 08:00 AM on 12/19/2014 onset of 101 degree fever, nausea, vomiting, diarrhea, generalized muscle pain and weakness. Symptoms still present at time of report, no treatment administered at this time.
5/27/21 at approximately 7PM patient stated having  Pain, severe itching, tenderness and swelling (hardness) the size of a quarter to the right arm injection site noted.   5/28/2021 at approximately 6:30pm, call to notify infection preventionist about Reaction to vaccine. Patient advice to take Benadryl. Patient stated taking 50 mg of Benadryl by mouth. At approximately 10:00 PM, patient stated she no longer had further itching to the injection site however showed nurse a picture and noted still redness to site. Nurse advised to continue to monitor, and notified if any worsen reaction occurs. Patient voiced understanding.
Swollen lips, face, arm and hands. Large reaction at the shot site. Shortness of breath by hour 9.
Fever 102 2 hrs p/shots, rash broke out on chest, stomach, arms, legs;
Pt was vaccinated with the Johnson and Johnson Vaccine on 5/3/21. he presented to the emergency room with a stroke on 5/15/2021. 50-year-old male presents emergency department with difficulty finding words and difficulty getting his hands to do what he wants.  Last known normal was 1030 the previous night when he went to bed. He has a past medical hx sign for controlled HTN, seasonal allergies and obesity with a bmi of 48.  Family members noticed him having difficulty finding words the morning  of admission and it got slightly worse throughout the day.  According to his wife he was holding the phone and could not dial the right numbers.  His hands were working but they could not follow instructions from what his brain wanted to do.  On evaluation the patient felt as though he was stuttering and could not get the right words.  No numbness or tingling.  No weakness on one side or the other.  wife and pt reported no prior problems with word finding or memory in the past and other than obesity and controlled HTN he was healthy. He does not smoke. he had no prior hx of atrial fibrillation. telemetry monitoring showed no atrial fibrillation. His LDL was 109, chol 167,trig 119, hdl 34. No prior hx of covid 19 infection. echo with normal EF, no thrombus. He received Physicial therapy and Occupational therapy and speech therapy.  He was discharged home on 5/17 on an aspirin. He was called on 5/22 and is still experiencing expressive aphasia and word finding difficulty. He previously worked full time as a machinist and has not been able to go back to work. He is also complaining of fatigue still.
excessive redness and soreness at imz site unexpected by patient based on prior experiences with pfizer vaccine. pt knows to contact md if worsening symptoms, addition of fever, or streaks from the area
This case was reported by a other health professional via call center representative and described the occurrence of pain in a 80-year-old patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain and erythema. On an unknown date, the outcome of the pain and erythema were unknown. It was unknown if the reporter considered the pain and erythema to be related to SHINGRIX. Additional details were provided as follows: The pharmacy student reported this case during click to chat forum. The age at vaccination was not reported but could be 79 or 80 years. The reporter reported the patient had been getting a lot of redness and pain. The reporter reported that they had very limited information regarding the adverse reaction. No further information was reported regarding the event.
Breakthrough case admission after three vaccines Moderna 2/26/21 Lot# 025A21A;  Moderna 3/26/21 Lot# 045A21A;  Moderna 12/6/21 Lot# 027H21B
PATIENT RECEIVED VACCINE THAT EXPERIENCED A TEMPERATURE EXCURSION, VACCINE WAS KEPT IN THE REFRIGERATOR FOR MORE THAN 30 DAYS. NO SIDE EFFECTS.
Fever, runny nose, cramps, coughing up Green And Black phlegm  (nose) difficulty breathing, fatigue and chills. Missed three consecutively days of work plus 1 trip to ER and still not feeling well.